JW Pharmaceutical Corporation

KOSE:A001060 Stock Report

Market Cap: ₩593.6b

JW Pharmaceutical Dividends and Buybacks

Dividend criteria checks 3/6

JW Pharmaceutical is a dividend paying company with a current yield of 1.65% that is well covered by earnings. Next payment date is on 28th April, 2025 with an ex-dividend date of 27th December, 2024.

Key information

1.7%

Dividend yield

0.06%

Buyback Yield

Total Shareholder Yield1.7%
Future Dividend Yield1.6%
Dividend Growth10.7%
Next dividend pay date28 Apr 25
Ex dividend date27 Dec 24
Dividend per share₩392.157
Payout ratio32%

Recent dividend and buyback updates

Do These 3 Checks Before Buying JW Pharmaceutical Corporation (KRX:001060) For Its Upcoming Dividend

Dec 24
Do These 3 Checks Before Buying JW Pharmaceutical Corporation (KRX:001060) For Its Upcoming Dividend

Recent updates

JW Pharmaceutical's (KRX:001060) Solid Earnings May Rest On Weak Foundations

Nov 23
JW Pharmaceutical's (KRX:001060) Solid Earnings May Rest On Weak Foundations

JW Pharmaceutical (KRX:001060) Seems To Use Debt Rather Sparingly

Aug 07
JW Pharmaceutical (KRX:001060) Seems To Use Debt Rather Sparingly

JW Pharmaceutical's (KRX:001060) Earnings Are Of Questionable Quality

Mar 21
JW Pharmaceutical's (KRX:001060) Earnings Are Of Questionable Quality

Is JW Pharmaceutical Corporation (KRX:001060) An Attractive Dividend Stock?

Apr 08
Is JW Pharmaceutical Corporation (KRX:001060) An Attractive Dividend Stock?

How Many JW Pharmaceutical Corporation (KRX:001060) Shares Do Institutions Own?

Mar 13
How Many JW Pharmaceutical Corporation (KRX:001060) Shares Do Institutions Own?

Is JW Pharmaceutical (KRX:001060) Using Too Much Debt?

Feb 15
Is JW Pharmaceutical (KRX:001060) Using Too Much Debt?

JW Pharmaceutical's(KRX:001060) Share Price Is Down 24% Over The Past Three Years.

Jan 19
JW Pharmaceutical's(KRX:001060) Share Price Is Down 24% Over The Past Three Years.

Do These 3 Checks Before Buying JW Pharmaceutical Corporation (KRX:001060) For Its Upcoming Dividend

Dec 24
Do These 3 Checks Before Buying JW Pharmaceutical Corporation (KRX:001060) For Its Upcoming Dividend

Would JW Pharmaceutical Corporation (KRX:001060) Be Valuable To Income Investors?

Nov 30
Would JW Pharmaceutical Corporation (KRX:001060) Be Valuable To Income Investors?

Upcoming Dividend Payment

TodayDec 25 2024Ex Dividend DateDec 27 2024Dividend Pay DateApr 28 2025122 days from Ex DividendBuy in the next 1 day to receive the upcoming dividend

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Whilst dividend payments have been stable, A001060 has been paying a dividend for less than 10 years.

Growing Dividend: A001060's dividend payments have increased, but the company has only paid a dividend for 8 years.

Dividend Yield vs Market

JW Pharmaceutical Dividend Yield vs Market
How does A001060 dividend yield compare to the market?
SegmentDividend Yield
Company (A001060)1.7%
Market Bottom 25% (KR)1.2%
Market Top 25% (KR)3.9%
Industry Average (Pharmaceuticals)1.1%
Analyst forecast (A001060) (up to 3 years)1.6%

Notable Dividend: A001060's dividend (1.65%) is higher than the bottom 25% of dividend payers in the KR market (1.24%).

High Dividend: A001060's dividend (1.65%) is low compared to the top 25% of dividend payers in the KR market (3.91%).

Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (32.2%), A001060's dividend payments are well covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (14.7%), A001060's dividend payments are thoroughly covered by cash flows.

Discover strong dividend paying companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 19:39
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

JW Pharmaceutical Corporation is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jisoo LeeDAOL Investment & Securities Co., Ltd.
Myung Sun LeeDB Financial Investment Co. Ltd.
Hyung Soo KimHanwha Investment & Securities Co., Ltd.